
Lawsuit Threat for Exposing a Sneaky Nigerian Doctor’s Sexual Misconduct Investigations
I woke up to a demand letter in my inbox from a lawyer representing Dr. Adegbenga Rabiu, threatening to sue me unless I delete my public interest journalism.
Reports tagged “Medical Licensing”, newest first. This tag follows an ongoing investigation: read the Medical Licensing: Who Gets to Practise? series in order →
This undercover investigation, spanning international borders, traces how a “doctor” from Nigeria who was suspended in South Africa — allegedly for fraud and misrepresentation — was able to obtain a medical license in Alberta, Canada, where he sent baby Alita home when she was hours away from dying.

I woke up to a demand letter in my inbox from a lawyer representing Dr. Adegbenga Rabiu, threatening to sue me unless I delete my public interest journalism.

I’ve been banned from every Alberta Health Services hospital for a year after a short visit back in March in which I calmly asked a nurse if a doctor would be available for an interview and left when told no.

Baby Alita died just hours after a visit to a “doctor” in Beaver Lodge, Alberta. According to her family, the doctor showed little care for her and sent her home, where she tragically passed away.

I confronted Dr. Adegbenga Oluwaseun Rabiu at his medical office in Moose Jaw, where he is treating children of unsuspecting rural communities, about his track record in Ontario of being banned for life from practicing there following sexual abuse investigations.

Dr. Anthony Amako Agomuoh of Yorkton, Saskatchewan, was charged by the RCMP with assault, resisting arrest, and assaulting a child with a weapon. He was found guilty of the assault-with-a-weapon charge, which he inflicted on his own child over a six-year period.

Alberta’s medical board, CPSA, continues to allow the infamous “dr” Imafidon Thomas Izekor to practice in Alberta after yet another misconduct finding stemming from Saskatchewan.
We’ll email you when we publish. No spam; unsubscribe anytime.
Thanks, you’re on the list. We’ll email you when we publish.